HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 564 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,164,358 | -21.9% | 45,381 | -57.6% | 0.03% | -18.9% |
| Q3 2022 | $6,616,000 | -21.8% | 106,910 | +0.8% | 0.04% | -28.8% |
| Q2 2022 | $8,458,000 | -10.2% | 106,049 | +18.4% | 0.05% | -35.0% |
| Q1 2022 | $9,420,000 | +8.8% | 89,536 | +11.4% | 0.08% | -2.4% |
| Q4 2021 | $8,657,000 | +14.4% | 80,338 | +16.3% | 0.08% | -13.7% |
| Q3 2021 | $7,567,000 | +526.4% | 69,076 | +435.6% | 0.10% | +578.6% |
| Q2 2021 | $1,208,000 | +3.2% | 12,897 | +1.4% | 0.01% | -6.7% |
| Q1 2021 | $1,170,000 | -91.3% | 12,713 | -92.7% | 0.02% | -92.5% |
| Q3 2020 | $13,459,000 | +592.7% | 173,262 | +395.6% | 0.20% | +485.3% |
| Q2 2020 | $1,943,000 | +69.3% | 34,957 | -9.8% | 0.03% | +9.7% |
| Q1 2020 | $1,148,000 | +168.9% | 38,757 | +228.4% | 0.03% | +287.5% |
| Q4 2019 | $427,000 | -82.8% | 11,800 | -87.0% | 0.01% | -83.7% |
| Q3 2019 | $2,480,000 | -52.7% | 91,080 | -58.2% | 0.05% | -49.0% |
| Q2 2019 | $5,248,000 | – | 218,129 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |